Clinical Trials in San Antonio

Showing 6901-6920 of 11,125 trials

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

NCT00394082

The purpose of this study is to evaluate the safety and tolerability of weekly ABI-007 in combination with bevacizumab. The evaluation of progression-free survival of weekly ABI-007 in combination with bevacizumab for patients with previously untreated advanced/metastatic breast cancer.

Metastatic Breast Cancer

Celgene50 participantsStarted Jun 2006

Melbourne, Florida, United States • Ocoee, Florida, United States • Niles, Illinois, United States +17 more locations

COMPLETEDPhase 3< 1 mile

Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer

NCT02776683

The objective of this trial is to evaluate the safety and tolerability of BI 695502 in combination with leucovorin/5-fluorouracil/oxaliplatin (mFOLFOX6) and as maintenance therapy (when applicable). As well as to evaluate the following efficacy parameters: Progression-free survival (PFS), objective response rate (proportion of patients with complete response \[CR\] plus partial response \[PR\]), overall survival (OS), duration of response (DOR), time to progression (TTP).

Colorectal Neoplasms

Boehringer Ingelheim123 participantsStarted Jun 2016

Phoenix, Arizona, United States • Anaheim, California, United States • Anaheim, California, United States +43 more locations

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer

Find Trials by Condition in San Antonio

Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors

A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas

Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer

Safety of Intravenous Neridronic Acid in CRPS

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza

A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia

Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly

A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma

Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®

Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)